Unlocking the Potential: Semaglutide's Impact on Alzheimer's and Parkinson's Disease in Animal Models
AD Meca, IKS Boboc, L Mititelu-Tartau… - Current Issues in …, 2024 - mdpi.com
Semaglutide (SEM), a glucagon-like peptide-1 receptor agonist, has garnered increasing
interest for its potential therapeutic effects in neurodegenerative disorders such as …
interest for its potential therapeutic effects in neurodegenerative disorders such as …
[HTML][HTML] Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson's disease
A Kumar, AK Gupta, PK Singh - AIMS Neuroscience, 2024 - aimspress.com
Parkinson's disease (PD) is a neurodegenerative disorder that involves the loss of
dopaminergic neurons, which leads to motor and non-motor symptoms that have a …
dopaminergic neurons, which leads to motor and non-motor symptoms that have a …